Hantavirus comparé au COVID, SRAS, MERS, Ebola, Lassa et Marburg
Comment le virus Andes se compare-t-il réellement aux autres virus émergents les plus souvent évoqués ? Tous les chiffres proviennent directement des fiches d'information de l'OMS et du CDC.
Dernière révision: 9 mai 2026 · Sources : pages thématiques de l'OMS et du CDC américain.
| Indicateur | ANDV1995 | SARS2003 | MERS2012 | EVD1976 | Lassa1969 | COVID2019 | MVD1967 |
|---|---|---|---|---|---|---|---|
| Taux de létalité | 30–40% | ~10% (≈50% in adults >65) | ~35% | ~50% (range 25–90%) | ~1% overall; ~15% hospitalised | ~0.5–1% IFR (ancestral, pre-vaccine) | ~50% (range 24–88%) |
| R0 (nombre de reproduction de base) | <1 (rare P2P clusters) | 2–4 | <1 in community; clusters in hospitals | 1.5–2.5 | <1 community; healthcare-associated clusters | 2–3 (ancestral); higher for later variants | 1–2 |
| Période d'incubation | 2–4 weeks (up to 6) | 2–10 days | 2–14 days (median 5) | 2–21 days | 6–21 days | 2–14 days (median 5) | 2–21 days |
| Mode de transmission | Inhaled rodent excreta; rare person-to-person (ANDV only) | Respiratory droplets, fomites, healthcare-associated | Camel-to-human; limited human-to-human in healthcare | Direct contact with body fluids; safe-burial practices critical | Inhalation/ingestion of rodent excreta; nosocomial human-to-human | Respiratory aerosols and droplets; pre-symptomatic spread | Direct contact with body fluids; bat exposure (caves) |
| Transmission interhumaine | Limitée | Oui | Limitée | Oui | Limitée | Oui | Oui |
| Traitement disponible | Supportive care, oxygen, ECMO; ribavirin investigational | Supportive care; no specific antiviral | Supportive care; no specific antiviral approved | Two monoclonal antibody therapies licensed (Inmazeb, Ebanga); supportive care | Ribavirin (early administration); supportive care | Antivirals (nirmatrelvir/ritonavir, remdesivir); supportive care | Supportive care; investigational antibodies and antivirals |
| Vaccin disponible | None licensed | None licensed (development halted after eradication) | None licensed (candidates in trials) | Ervebo (rVSV-ZEBOV, licensed 2019); Zabdeno/Mvabea regimen | None licensed (CEPI-funded candidates in trials) | Multiple licensed mRNA, viral-vector and protein subunit vaccines | None licensed (Sabin/cAd3-Marburg in trials) |
| Distribution géographique | Argentina, Chile, with imported clusters worldwide (2026) | 29 countries during 2002–2003; eradicated in humans since 2004 | Arabian Peninsula; sporadic exports to 27 countries | Sub-Saharan Africa; sporadic exports | West Africa (Nigeria, Sierra Leone, Liberia, Guinea) | Global pandemic since 2020; now endemic seasonal circulation | Sub-Saharan Africa; rare exports |
| Première identification | 1995 | 2003 | 2012 | 1976 | 1969 | 2019 | 1967 |
| Famille de virus | Hantaviridae (Bunyavirales) | Coronaviridae | Coronaviridae | Filoviridae | Arenaviridae | Coronaviridae | Filoviridae |
| Hôte réservoir | Long-tailed pygmy rice rat (Oligoryzomys longicaudatus) | Horseshoe bats; civets as intermediate host | Dromedary camels (bats as ancestral host) | Fruit bats (suspected); primates amplifying host | Multimammate rat (Mastomys natalensis) | Bats (likely ancestral); intermediate host debated | Egyptian rousette fruit bat (Rousettus aegyptiacus) |
Head-to-head deep dives
Want a focused, two-disease comparison? Each page goes deeper than the row table above — full metric grid, detail cards, schema.org MedicalCondition markup.
Profils des maladies
Cliquez sur une maladie pour afficher son profil. Chaque fiche renvoie à la source principale de l'OMS ou du CDC — et, si disponible, à un article plus complet sur HantaCount.
Hantavirus (Andes virus, ANDV)
ANDVAndes virus is the only hantavirus with documented person-to-person transmission. The 2026 MV Hondius cluster is being closely watched because its cruise-ship setting matches the close-contact conditions where ANDV chains have appeared historically.
Hantavirus (Andes virus, ANDV)
ANDVAndes virus is the only hantavirus with documented person-to-person transmission. The 2026 MV Hondius cluster is being closely watched because its cruise-ship setting matches the close-contact conditions where ANDV chains have appeared historically.
- Première identification
- 1995
- Famille de virus
- Hantaviridae (Bunyavirales)
- Hôte réservoir
- Long-tailed pygmy rice rat (Oligoryzomys longicaudatus)
SARS (SARS-CoV-1)
SARSSARS spread efficiently through close respiratory contact, particularly in hospitals. Aggressive case isolation and contact tracing, not pharmaceuticals, ended the outbreak — and there has been no human SARS-CoV-1 case since 2004.
SARS (SARS-CoV-1)
SARSSARS spread efficiently through close respiratory contact, particularly in hospitals. Aggressive case isolation and contact tracing, not pharmaceuticals, ended the outbreak — and there has been no human SARS-CoV-1 case since 2004.
- Première identification
- 2003
- Famille de virus
- Coronaviridae
- Hôte réservoir
- Horseshoe bats; civets as intermediate host
MERS (MERS-CoV)
MERSMERS-CoV has high lethality but does not transmit efficiently between humans outside healthcare settings. Most cases trace back to direct or indirect contact with infected dromedary camels.
MERS (MERS-CoV)
MERSMERS-CoV has high lethality but does not transmit efficiently between humans outside healthcare settings. Most cases trace back to direct or indirect contact with infected dromedary camels.
- Première identification
- 2012
- Famille de virus
- Coronaviridae
- Hôte réservoir
- Dromedary camels (bats as ancestral host)
Ebola virus disease (Zaire)
EVDEbola is highly lethal but requires direct contact with body fluids to transmit. The licensure of Ervebo in 2019 and effective monoclonal antibodies have transformed outbreak response.
Ebola virus disease (Zaire)
EVDEbola is highly lethal but requires direct contact with body fluids to transmit. The licensure of Ervebo in 2019 and effective monoclonal antibodies have transformed outbreak response.
- Première identification
- 1976
- Famille de virus
- Filoviridae
- Hôte réservoir
- Fruit bats (suspected); primates amplifying host
Lassa fever
LassaAbout 80% of Lassa infections are mild or asymptomatic, masking transmission in endemic regions. Person-to-person spread is mostly limited to healthcare settings and household contact with body fluids.
Lassa fever
LassaAbout 80% of Lassa infections are mild or asymptomatic, masking transmission in endemic regions. Person-to-person spread is mostly limited to healthcare settings and household contact with body fluids.
- Première identification
- 1969
- Famille de virus
- Arenaviridae
- Hôte réservoir
- Multimammate rat (Mastomys natalensis)
COVID-19 (SARS-CoV-2)
COVIDSARS-CoV-2 spreads efficiently before symptoms begin, which is exactly the property that drove the 2020 pandemic. Hantaviruses lack this trait, which is the single biggest reason ANDV is not expected to behave like COVID.
COVID-19 (SARS-CoV-2)
COVIDSARS-CoV-2 spreads efficiently before symptoms begin, which is exactly the property that drove the 2020 pandemic. Hantaviruses lack this trait, which is the single biggest reason ANDV is not expected to behave like COVID.
- Première identification
- 2019
- Famille de virus
- Coronaviridae
- Hôte réservoir
- Bats (likely ancestral); intermediate host debated
Marburg virus disease
MVDMarburg shares transmission and clinical features with Ebola but no licensed vaccine yet exists. Outbreaks have been small and contained through case isolation and safe burial practices.
Marburg virus disease
MVDMarburg shares transmission and clinical features with Ebola but no licensed vaccine yet exists. Outbreaks have been small and contained through case isolation and safe burial practices.
- Première identification
- 1967
- Famille de virus
- Filoviridae
- Hôte réservoir
- Egyptian rousette fruit bat (Rousettus aegyptiacus)
Comparaison des suivis d'hantavirus — 2026
Six suivis ont été lancés en quelques jours après la publication du DON-599 de l'OMS. Voici une comparaison honnête, fonctionnalité par fonctionnalité, pour vous aider à choisir celui qui vous convient le mieux — même si ce n'est pas le nôtre.
| Fonctionnalité | HantaCount | HantavirusMap | HantaCounter | Hantavirus.live | Live Map | Tracker.io |
|---|---|---|---|---|---|---|
| Languages supported | 10 (en, tr, ar, es, nl, fr, de, ja, fi, ru) | 1 (en) | 1 (en) | 1 (en) | 2 (en, es) | 1 (en) |
| Open dataset (CC-BY) | JSON + CSV | |||||
| Source-attributed counts | every count linked | footer only | ||||
| Long-form explainers | 5 articles, medically reviewed | FAQ only | ||||
| Medical reviewer disclosed | ||||||
| Methodology page | ||||||
| Ads / paywall / affiliates | none | no ads | ads present | |||
| Map view | ||||||
| Auto-updating from primary sources | WHO/ECDC RSS + manual approval | 30 min cadence | ||||
| OpenGraph live counter image | ||||||
| RTL/Arabic layout |
Where HantaCount wins
- • Five languages including Arabic with full RTL layout
- • Open dataset (CC-BY-4.0) as JSON + CSV
- • Five long-form explainers, all medically reviewed
- • Every count is linked to its primary source document
- • Auto-updating OG image — embed-friendly for journalists
- • No ads, no paywall, no affiliates — ever
Where others may suit you better
- • Hantavirus.live shows the live AIS ship position — useful if you only care about MV Hondius' whereabouts.
- • HantavirusMap has broader historical context across all hantavirus species, not just the 2026 outbreak.
- • HantaCounter refreshes every 30 minutes — slightly more frequent than our hourly cycle.
How we built this comparison
We visited each site on May 8, 2026 and recorded the visible features. We did not test paid tiers (none of these sites have one) and we did not include private dashboards. If anything is wrong — especially something that disadvantages a competitor — email hello@hantacount.com and we'll fix it. Honest comparison or none.